Citation: V. Blaton et E. Muls, PROCEEDINGS OF THE 68TH CONGRESS OF THE EUROPEAN-ATHEROSCLEROSIS-SOCIETY - BRUGGE, BELGIUM, 7-10 MAY 1997 - PREFACE, Atherosclerosis (Amsterdam), 137, 1998, pp. 9-9
Citation: E. Muls et al., COST-EFFECTIVENESS OF PRAVASTATIN IN SECONDARY PREVENTION OF CORONARYHEART-DISEASE - COMPARISON BETWEEN BELGIUM AND THE UNITED-STATES OF APROJECTED RISK MODEL, Atherosclerosis (Amsterdam), 137, 1998, pp. 111-116
Citation: E. Muls et al., CORONARY-HEART-DISEASE RISK-FACTORS AND LDL-CHOLESTEROL-LOWERING EFFICACY OF FIBRATES AND SIMVASTATIN, Clinical drug investigation, 14(2), 1997, pp. 98-108
Authors:
PASMAN WJ
WESTERTERPPLANTENGA MS
MULS E
VANSANT G
VANREE J
SARIS WHM
Citation: Wj. Pasman et al., THE EFFECTIVENESS OF LONG-TERM FIBER SUPPLEMENTATION ON WEIGHT MAINTENANCE IN WEIGHT-REDUCED WOMEN, International journal of obesity, 21(7), 1997, pp. 548-555
Citation: E. Muls et al., EFFECTS OF INITIAL BMI AND ON-TREATMENT WEIGHT CHANGE ON THE LIPID-LOWERING EFFICACY OF FIBRATES, International journal of obesity, 21(2), 1997, pp. 155-158
Citation: E. Muls et G. Vansant, DOES APO-E POLYMORPHISM MODULATE FASTING AND POSTPRANDIAL LIPOPROTEINS IN MORBIDLY OBESE WOMEN WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetes, 45, 1996, pp. 1181-1181
Authors:
MULS E
HOFMANS E
DROUSSIN AM
VERCAMMEN C
VANSANT G
Citation: E. Muls et al., SEQUENTIAL MANAGEMENT OF HYPERCHOLESTEROLEMIA WITH A FIBRATE AND SIMVASTATIN - THE BELGIAN GENERAL-PRACTITIONERS TRIAL, Clinical drug investigation, 9(2), 1995, pp. 116-126
Citation: E. Muls et al., IS WEIGHT CYCLING DETRIMENTAL TO HEALTH - A REVIEW OF THE LITERATURE IN HUMANS, International journal of obesity, 19, 1995, pp. 46-50
Citation: E. Muls et al., COMBINED TREATMENT WITH SIMVASTATIN AND ACIPIMOX IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH ELEVATED LIPOPROTEIN(A), NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(2), 1994, pp. 78-82
Authors:
MULS E
KEMPEN K
VANSANT G
COBBAERT C
SARIS W
Citation: E. Muls et al., THE EFFECTS OF WEIGHT-LOSS AND APOLIPOPROTEIN-E POLYMORPHISM ON SERUM-LIPIDS, APOLIPOPROTEIN-A-I AND APOLIPOPROTEIN-B, AND LIPOPROTEIN(A), International journal of obesity, 17(12), 1993, pp. 711-716